Edesa Biotech, Inc.

Contributing Author

Recent Articles by Edesa Biotech, Inc.

Aug-13	Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results EDSA GlobeNewswire
Jun-11	Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors EDSA +8.45% GlobeNewswire
Jun-05	Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury EDSA -22.99% GlobeNewswire
May-19	Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference EDSA +32.78% GlobeNewswire
May-14	Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results EDSA EDSA -10.68% GlobeNewswire
Mar-31	Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit EDSA EDSA +6.12% GlobeNewswire
Mar-26	Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment EDSA -10.81% GlobeNewswire
Feb-24	Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study EDSA +67.96% GlobeNewswire
Feb-13	Edesa Biotech Reports Fiscal 1st Quarter 2026 Results EDSA GlobeNewswire
Dec-12	Edesa Biotech Reports Fiscal Year 2025 Results EDSA EDSA -16.09% GlobeNewswire
Oct-31	Edesa Biotech Announces Upcoming Conference Schedule EDSA EDSA -6.45% GlobeNewswire
Oct-28	Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study EDSA -17.87% GlobeNewswire
Aug-08	Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results EDSA GlobeNewswire
May-14	Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results EDSA GlobeNewswire